Streetbeat News

Analyst Ratings

RGNX

Raymond James analyst Dane Leone reinstated Regenxbio (NASDAQ:RGNX) with an Outperform rating and set a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:48 am

WKC

JP Morgan analyst John Royall initiates coverage on World Kinect (NYSE:WKC) with a Neutral rating and a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:45 am

ANAB

Stifel analyst Alex Schwartz has initiated coverage on AnaptysBio (NASDAQ:ANAB) with a Buy rating and set a price target of $50. This new coverage could influence investor sentiment and potentially impact AnaptysBio's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:43 am

CFLT

Stifel analyst Brad Reback initiates coverage on Confluent (NASDAQ:CFLT) with a Buy rating and a price target of $40.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:40 am

PATH

Scotiabank analyst Nick Altmann initiates coverage on UiPath (NYSE:PATH) with a Sector Perform rating, indicating a neutral outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:38 am

BCYC

Needham analyst Ami Fadia reiterated a Buy rating on Bicycle Therapeutics (NASDAQ:BCYC) and maintained a $43 price target.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:34 am

NEO

Needham analyst Mike Matson maintains a Buy rating on NeoGenomics (NASDAQ:NEO) and raises the price target from $21 to $24.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:32 am

M

Telsey Advisory Group analyst Dana Telsey reiterated a 'Market Perform' rating on Macy's (NYSE:M) and maintained a $15 price target.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:31 am

SPT

Piper Sandler analyst Clarke Jeffries has maintained an Overweight rating on Sprout Social (NASDAQ:SPT) and increased the price target from $62 to $66.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:27 am

DFIN

Needham analyst Kyle Peterson has maintained a Buy rating on Donnelley Financial Solutions (DFIN) and increased the price target from $65 to $72.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:23 am